Company intelligence / Profile preview

Dongyu Investment

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

Dongyu Investment, also known as Dongyu Capital, is a prominent healthcare-focused private equity and venture capital firm based in Beijing, China. The firm specializes in identifying and supporting high-growth companies across the life sciences, biotechnology, and medical device sectors. Dongyu Investment provides strategic capital and operational expertise to innovative enterprises at various stages of development, ranging from early-stage startups to pre-IPO companies. Its portfolio includes several leading Chinese biotech firms, such as Mabwell, Clover Biopharmaceuticals, and InnoCare Pharma, reflecting its significant influence in the regional healthcare investment landscape.

Industry: Investors

Beyond the preview

Go deeper on Dongyu Investment.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dongyu Investment.

Explore the full profile